Literature DB >> 27023285

Strategies to target non-T-cell HIV reservoirs.

Jonah B Sacha1, Lishomwa C Ndhlovu.   

Abstract

PURPOSE OF REVIEW: A central question for the HIV cure field is to determine new ways to target clinically relevant, latently and actively replicating HIV-infected cells beyond resting memory CD4 T cells, particularly in anatomical areas of low drug penetrability. RECENT
FINDINGS: HIV eradication strategies being positioned for targeting HIV for extinction in the CD4 T-cell compartment may also show promise in non-CD4 T-cells reservoirs. Furthermore, several exciting novel therapeutic approaches specifically focused on HIV clearance from non-CD4 T-cell populations are being developed.
SUMMARY: Although reservoir validity in these non-CD4 T cells continues to remain debated, this review will highlight recent advances and make an argument as to their clinical relevancy as we progress towards an HIV cure.

Entities:  

Mesh:

Year:  2016        PMID: 27023285      PMCID: PMC4947377          DOI: 10.1097/COH.0000000000000283

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  55 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes.

Authors:  Eyal Afergan; Hila Epstein; Rachel Dahan; Nickolay Koroukhov; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  J Control Release       Date:  2008-09-04       Impact factor: 9.776

Review 3.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

4.  Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1.

Authors:  Grant R Campbell; Rachel S Bruckman; Yen-Lin Chu; Stephen A Spector
Journal:  J Biol Chem       Date:  2014-12-24       Impact factor: 5.157

Review 5.  How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?

Authors:  Jintanat Ananworanich; Karine Dubé; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

6.  Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats.

Authors:  Lachlan R Gray; Daniel Cowley; Emma Crespan; Casey Welsh; Charlene Mackenzie; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-25       Impact factor: 2.205

7.  Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.

Authors:  Mieke Gouwy; Sofie Struyf; Samuel Noppen; Evemie Schutyser; Jean-Yves Springael; Marc Parmentier; Paul Proost; Jo Van Damme
Journal:  Mol Pharmacol       Date:  2008-05-09       Impact factor: 4.436

8.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

9.  Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function.

Authors:  K C Jambo; D H Banda; A M Kankwatira; N Sukumar; T J Allain; R S Heyderman; D G Russell; H C Mwandumba
Journal:  Mucosal Immunol       Date:  2014-01-29       Impact factor: 7.313

10.  A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.

Authors:  Laura K DeMaster; Xiaohe Liu; D Jake VanBelzen; Benjamin Trinité; Lingjie Zheng; Luis M Agosto; Stephen A Migueles; Mark Connors; Lidia Sambucetti; David N Levy; Alexander O Pasternak; Una O'Doherty
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

View more
  10 in total

Review 1.  Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment.

Authors:  Yuqing Gong; Pallabita Chowdhury; Prashanth K B Nagesh; Theodore J Cory; Chelsea Dezfuli; Sunitha Kodidela; Ajay Singh; Murali M Yallapu; Santosh Kumar
Journal:  Expert Opin Drug Deliv       Date:  2019-07-24       Impact factor: 6.648

2.  TGF-β Signaling Supports HIV Latency in a Memory CD4+ T Cell Based In Vitro Model.

Authors:  Sydney Bergstresser; Deanna A Kulpa
Journal:  Methods Mol Biol       Date:  2022

3.  Single Genome Sequencing of Expressed and Proviral HIV-1 Envelope Glycoprotein 120 (gp120) and nef Genes.

Authors:  David J Nolan; Susanna L Lamers; Rebecca Rose; James J Dollar; Marco Salemi; Michael S McGrath
Journal:  Bio Protoc       Date:  2017-06-20

4.  Role of Tunneling Nanotube-like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread.

Authors:  George Okafo; Silvana Valdebenito; Maribel Donoso; Ross Luu; David Ajasin; Brendan Prideaux; Santhi Gorantla; Eliseo A Eugenin
Journal:  J Immunol       Date:  2020-10-09       Impact factor: 5.422

5.  Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency.

Authors:  Gideon Wolf; Nevil J Singh
Journal:  Viral Immunol       Date:  2021-02-17       Impact factor: 2.175

Review 6.  Are T cells the only HIV-1 reservoir?

Authors:  Abraham Joseph Kandathil; Sho Sugawara; Ashwin Balagopal
Journal:  Retrovirology       Date:  2016-12-20       Impact factor: 4.602

Review 7.  Factors Associated with the Size of HIV DNA Reservoir.

Authors:  Ni-Dan Wang; Tai-Sheng Li
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

Review 8.  Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

Authors:  Casey K Hua; Margaret E Ackerman
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

9.  Targeting the HIV-infected brain to improve ischemic stroke outcome.

Authors:  Luc Bertrand; Fannie Méroth; Marie Tournebize; Ana Rachel Leda; Enze Sun; Michal Toborek
Journal:  Nat Commun       Date:  2019-05-01       Impact factor: 14.919

10.  Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection.

Authors:  Madhavan Nair; Vidya Sagar; Sudheesh Pilakka-Kanthikeel
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.